These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8746206)

  • 1. Lusitropic effects of a Ca2+ sensitization with a new cardiotonic agent, MCI-154, on diseased human hearts.
    Mori M; Takeuchi M; Takaoka H; Yokoyama M
    Cardiovasc Res; 1995 Dec; 30(6):915-22. PubMed ID: 8746206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen-saving effect of a new cardiotonic agent, MCI-154, in diseased human hearts.
    Mori M; Takeuchi M; Takaoka H; Hata K; Hayashi Y; Yamakawa H; Yokoyama M
    J Am Coll Cardiol; 1997 Mar; 29(3):613-22. PubMed ID: 9060901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure.
    Asanoi H; Ishizaka S; Kameyama T; Ishise H; Sasayama S
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):268-74. PubMed ID: 7511757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
    Abe Y; Ishisu R; Onishi K; Sekioka K; Narimatsu A; Nakano T
    J Pharmacol Exp Ther; 1996 Feb; 276(2):433-9. PubMed ID: 8632307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1087-95. PubMed ID: 1602375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
    Joho S; Asanoi H; Ishizaka S; Kameyama T; Inoue H
    J Card Fail; 2002 Dec; 8(6):423-30. PubMed ID: 12528096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
    Shinke T; Shite J; Takaoka H; Hata K; Inoue N; Yoshikawa R; Matsumoto H; Masai H; Watanabe S; Ozawa T; Otake H; Matsumoto D; Hirata K; Yokoyama M
    Am Heart J; 2007 Oct; 154(4):645.e1-8. PubMed ID: 17892985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
    Sonntag S; Sundberg S; Lehtonen LA; Kleber FX
    J Am Coll Cardiol; 2004 Jun; 43(12):2177-82. PubMed ID: 15193677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
    Givertz MM; Andreou C; Conrad CH; Colucci WS
    Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Left ventricular peak systolic pressure/end-systolic volume ratio change after dobutamine infusion for predicting left ventricular contractile reserve: comparison with Emax].
    Sekido M; Uemura R; Takayama M; Kiuchi K; Nejima J; Takano T
    J Cardiol; 2002 Feb; 39(2):75-84. PubMed ID: 11873438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of normal aging on left ventricular lusitropic, inotropic, and chronotropic responses to dobutamine.
    Hees PS; Fleg JL; Mirza ZA; Ahmed S; Siu CO; Shapiro EP
    J Am Coll Cardiol; 2006 Apr; 47(7):1440-7. PubMed ID: 16580534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different responses of non-ischemic and post-ischemic myocardium towards Ca2+ sensitization.
    Korbmacher B; Sunderdiek U; Selcan G; Arnold G; Schipke JD
    J Mol Cell Cardiol; 1997 Aug; 29(8):2053-66. PubMed ID: 9281438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanoenergetic effect of pimobendan in failing dog hearts.
    Goto Y; Hata K
    Heart Vessels; 1997; Suppl 12():103-5. PubMed ID: 9476556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proof for piroximone's inotropic influence; can it safely be used in coronary artery disease? Analysis of end-systolic pressure-volume relations (conductance technique).
    Thormann J; Liebrich A; Mitrovic V; Strasser R; Dieterich HA; Schlepper M
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):50-62. PubMed ID: 1383631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance.
    Cheng CP; Noda T; Nordlander M; Ohno M; Little WC
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1232-41. PubMed ID: 8138936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [End-systolic pressure-volume relationships obtained by conductance catheter and transient inferior vena caval occlusion: their clinical usefulness].
    Kameyama T; Asanoi H; Ishizaka S; Nozawa T; Fujita M; Sasayama S
    J Cardiol; 1991; 21(2):473-80. PubMed ID: 1668750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of NKH477, a new water-soluble forskolin derivative, on arterial-ventricular coupling and mechanical energy transduction in patients with left ventricular systolic dysfunction: comparison with dobutamine.
    Mori M; Takeuchi M; Takaoka H; Hata K; Hayashi Y; Yokoyama M
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):310-6. PubMed ID: 7526066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.